Posts
January 05 2021
Benessere Capital Acquisition Corp. announced the closing of its initial public offering in the amount of $100,000,000. EGS acted as counsel to Benessere Capital Acquisition Corp.
January 05 2021
Megalith Financial Acquisition Corp. (now known as BM Technologies, Inc.) announced the completion of its previously announced business combination with BankMobile Technologies, Inc. EGS acted as counsel to Megalith Financial Acquisition Corp.
January 05 2021
Client Alert: CDC Recommends Order of Allocation of COVID-19 Vaccine
The Centers for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) has issued an Interim Recommendation for Allocation of the COVID-19 vaccine detailing the recommended order by which the COVID-19 vaccination should be offered to individuals.
Click here to read the alert.
December 31 2020
Castor Maritime Inc. announced the closing of its registered direct offering in the amount of $18,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.
December 30 2020
KULR Technology Group announced the closing of their offering in the amount of $8,000,000. EGS acted as counsel to Lake Street Capital Markets, LLC and Maxim Group LLC, the co-placement agents for the offering.
December 29 2020
Client Alert: Time to Update Your New Hire Paperwork with New Tax Withholding Forms and Health Insurance Notices
The federal and New York State government have recently issued updated tax withholding forms for employees. The 2021 IRS Form W-4 Employee’s Withholding Certificate is available here. The 2021 NYS Form IT-2104 Employee Withholding Allowance Certificate, available here.
Click here to read the alert.
December 28 2020
7GC & Co. Holdings Inc. announced the closing of its initial public offering in the amount of $230,000,000. EGS acted as counsel to 7GC & Co. Holdings Inc.
December 28 2020
CF Acquisition Corp. IV announced the closing of its initial public offering in the amount of $500,000,000. EGS acted as counsel to CF Acquisition Corp. IV.